Novartis AG (SWX:NOVN)
Switzerland
· Delayed Price · Currency is CHF 126.28
+0.28 (0.22%)
Jun 26, 2026, 5:30 PM CET
Novartis AG Employees
Novartis AG had 75,267 employees as of December 31, 2025. The number of employees decreased by 616 or -0.81% compared to the previous year.
Employees
75,267
Change (1Y)
-616
Growth (1Y)
-0.81%
Revenue / Employee
602.95K CHF
Profits / Employee
144.23K CHF
Market Cap
231.16B
Employees Chart
Employees History
| Date | Employees | Change | Growth |
|---|---|---|---|
| Dec 31, 2025 | 75,267 | -616 | -0.81% |
| Dec 31, 2024 | 75,883 | -174 | -0.23% |
| Dec 31, 2023 | 76,057 | -25,646 | -25.22% |
| Dec 31, 2022 | 101,703 | -2,620 | -2.51% |
| Dec 31, 2021 | 104,323 | -1,471 | -1.39% |
| Dec 31, 2020 | Pro | Pro | Pro |
| Dec 31, 2019 | Pro | Pro | Pro |
| Dec 31, 2018 | Pro | Pro | Pro |
| Dec 31, 2017 | Pro | Pro | Pro |
| Dec 31, 2016 | Pro | Pro | Pro |
Related Stocks
| Company Name | Employees |
|---|---|
| Roche Holding AG | 103,249 |
| Galderma Group AG | 7,676 |
| Lonza Group AG | 20,000 |
| Sandoz Group AG | 22,356 |
| Alcon | 25,000 |
| Straumann Holding AG | 11,821 |
| Sonova Holding AG | 18,590 |
| Bachem Holding AG | 2,595 |
Novartis AG News
- 2 days ago - The Zacks Analyst Blog Highlights JPMorgan, Novartis, Qualcomm, Genie and ImmuCell - Nasdaq
- 2 days ago - Top Stock Reports for JPMorgan, Novartis & Qualcomm - Nasdaq
- 3 days ago - Novartis Eyes $5 Billion Pluvicto Opportunity - GuruFocus
- 3 days ago - Novartis Targets Hard-to-Treat Cancers - GuruFocus
- 4 days ago - Pre-Market Most Active for Jun 24, 2026 : WEN, NOK, ABSI, RUN, SQQQ, SPCX, CCXI, NVS, NIO, INFQ, AMC, SMR - Nasdaq
- 4 days ago - Antares Therapeutics signs potential $1.9 billion cancer drug deal with Novartis - Reuters
- 4 days ago - Antares Therapeutics Enters Agreement with Novartis to Discover, Develop and Commercialize First-in-Class Cancer Therapies - Business Wire
- 4 days ago - Zacks Investment Ideas feature highlights: IBB, Novartis, Pfizer and Eli Lilly's - Nasdaq